Profund Advisors LLC Cytokinetics Inc Transaction History

Profund Advisors LLC

$2.67 Billion
Q4 2024

A detailed history of Profund Advisors LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Profund Advisors LLC holds 35,713 shares of CYTK stock, worth $1.62 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

35,713

Previous 46,052 22.45%

Holding current value

$1.62 Million

Previous $2.43 Million 30.93%

% of portfolio

0.06%

Previous 0.09%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$46.36 - $58.62 $479,316 - $606,072	-10,339 Reduced 22.45%	35,713 $1.68 Million
Q3 2024 Nov 13, 2024	SELL	$51.22 - $60.16 $300,610 - $353,079	-5,869 Reduced 11.3%	46,052 $2.43 Million
Q2 2024 Aug 13, 2024	BUY	$47.86 - $75.05 $1.22 Million - $1.91 Million	25,400 Added 95.77%	51,921 $2.81 Million
Q1 2024 May 08, 2024	SELL	$63.75 - $108.06 $1.35 Million - $2.29 Million	-21,228 Reduced 44.46%	26,521 $1.86 Million
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $50,265 - $156,126	1,870 Added 4.08%	47,749 $3.99 Million
Q3 2023 Nov 13, 2023	BUY	$29.46 - $36.61 $13,168 - $16,364	447 Added 0.98%	45,879 $1.35 Million
Q2 2023 Aug 10, 2023	BUY	$32.62 - $40.75 $174,777 - $218,338	5,358 Added 13.37%	45,432 $1.48 Million
Q1 2023 May 11, 2023	BUY	$33.36 - $45.71 $1.15 Million - $1.57 Million	34,405 Added 606.9%	40,074 $1.41 Million
Q4 2022 Feb 02, 2023	SELL	$35.77 - $51.11 $20,531 - $29,337	-574 Reduced 9.19%	5,669 $259,000
Q3 2022 Nov 04, 2022	BUY	$38.54 - $54.52 $18,383 - $26,006	477 Added 8.27%	6,243 $302,000
Q2 2022 Aug 01, 2022	SELL	$33.93 - $48.92 $36,949 - $53,273	-1,089 Reduced 15.89%	5,766 $227,000
Q1 2022 May 10, 2022	SELL	$29.74 - $46.0 $21,293 - $32,936	-716 Reduced 9.46%	6,855 $252,000
Q4 2021 Feb 08, 2022	SELL	$34.35 - $46.38 $13,293 - $17,949	-387 Reduced 4.86%	7,571 $345,000
Q3 2021 Nov 12, 2021	BUY	$18.54 - $35.74 $147,541 - $284,418	7,958 New	7,958 $284,000
Q4 2018 Feb 14, 2019	SELL	$5.91 - $9.29 $59,271 - $93,169	-10,029 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$6.4 - $9.85 $6,182 - $9,515	-966 Reduced 8.79%	10,029 $99,000
Q2 2018 Aug 13, 2018	BUY	$6.9 - $9.9 $75,865 - $108,850	10,995 New	10,995 $91,000

Others Institutions Holding CYTK

# of Institutions

395

Shares Held

122M

Call Options Held

3.46M

Put Options Held

1.86M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.27B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account

Profund Advisors LLC Cytokinetics Inc Transaction History